Bridgeway Capital Management’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Bridgeway Capital Management’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-57,000	Closed	-$231K	–	1404
2023 Q4	$231K	Buy	+57,000	New	+$174K	0.01%	1110

Bridgeway Capital Management's THRX Position: Q1 2024 in Review

Bridgeway Capital Management sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 57,000 shares — an estimated $231K sold.

Bridgeway Capital Management first reported a position in THRX in Q4 2023 and held it in 1 quarter. The position peaked at $231K in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

Bridgeway Capital Management reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Bridgeway Capital Management sold 57,000 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $231K.
Bridgeway Capital Management first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Bridgeway Capital Management's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $231K in Q4 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Bridgeway Capital Management's 13F filing for Q1 2024, filed 15 May 2024.